Pravastatin Sodium Tablet
Product Images NDC 60505-0170

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 60505-0170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mg-90btl (10mg 90btl)

Label for Pravastatin Sodium Tablets USP 10 mg, bottle containing 90 tablets. The label indicates storage instructions, dosage information, and manufacturer details for Apotex Corp. The NDC number 60505-0168-9 is visible along with a barcode. The label emphasizes protection from light and moisture and specifies dispensing in a tight, light-resistant container.*

FDA Label Image

20mg-90btl (20mg 90btl)

Label for Pravastatin Sodium Tablets, USP 20 mg, oral tablets by Apotex Corp. The label includes storage instructions, dosage guidance to see package insert, quantity of 90 tablets, NDC 60505-0169-9, and manufacturer details for Apotex Inc. Toronto, Canada, and Apotex Corp. Weston, Florida.*

FDA Label Image

40mg-90btl (40mg 90btl)

Label for Pravastatin Sodium Tablets, USP, 40 mg, manufactured and labeled by Apotex Corp. The label indicates a package size of 90 tablets with oral dosage form. Storage instructions specify 20°C to 25°C, with excursions permitted from 15°C to 30°C, and protection from light and moisture is advised. The label includes the National Drug Code (NDC) 60505-0170-9 and barcode.*

FDA Label Image

80mg-90btl (80mg 90btl)

Label for Pravastatin Sodium Tablets, USP 80 mg, oral tablet dosage form. The label shows a package size of 90 tablets and is manufactured by Apotex Corp. Instructions include storage at 20°C to 25°C and protection from light and moisture. The label also lists the National Drug Code (NDC) 60505-1323-9.*

FDA Label Image

Pravastatin-fig1 (Pravastatin Fig1)

A Kaplan-Meier survival curve illustrating the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over approximately five years. The graph compares two groups: placebo and pravastatin, showing higher survival without event in the pravastatin group with a logrank P value of 0.0001, indicating statistical significance.*

FDA Label Image

Pravastatin-structure (Pravastatin Structure)

Chemical structure of pravastatin sodium, depicting its molecular formula C23H35NaO7 and molecular weight 446.52.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.